HK1201064A1 - 有用於治療人類乳頭瘤病毒的被胍基取代的聚醯胺 - Google Patents

有用於治療人類乳頭瘤病毒的被胍基取代的聚醯胺

Info

Publication number
HK1201064A1
HK1201064A1 HK15101532.6A HK15101532A HK1201064A1 HK 1201064 A1 HK1201064 A1 HK 1201064A1 HK 15101532 A HK15101532 A HK 15101532A HK 1201064 A1 HK1201064 A1 HK 1201064A1
Authority
HK
Hong Kong
Prior art keywords
guanidinyl
papilloma virus
human papilloma
treating human
polyamides useful
Prior art date
Application number
HK15101532.6A
Other languages
English (en)
Inventor
詹姆士．
．巴什金
特裡．
．愛德華茲
克裡斯多夫．費舍爾
小喬治．
．哈裡斯
凱文．
．科勒
Original Assignee
Nanovir Llc
Univ Missouri
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanovir Llc, Univ Missouri filed Critical Nanovir Llc
Publication of HK1201064A1 publication Critical patent/HK1201064A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C07K14/003—Peptide-nucleic acids (PNAs)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polyamides (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Materials For Medical Uses (AREA)
HK15101532.6A 2011-10-10 2015-02-11 有用於治療人類乳頭瘤病毒的被胍基取代的聚醯胺 HK1201064A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161545311P 2011-10-10 2011-10-10
PCT/US2012/059604 WO2013055825A2 (en) 2011-10-10 2012-10-10 Guanidinyl-substituted polyamides useful for treating human papilloma virus

Publications (1)

Publication Number Publication Date
HK1201064A1 true HK1201064A1 (zh) 2015-08-21

Family

ID=48042465

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15101532.6A HK1201064A1 (zh) 2011-10-10 2015-02-11 有用於治療人類乳頭瘤病毒的被胍基取代的聚醯胺

Country Status (12)

Country Link
US (1) US9133228B2 (zh)
EP (1) EP2751096A4 (zh)
JP (1) JP2015502330A (zh)
KR (1) KR20140074996A (zh)
CN (1) CN104024247B (zh)
AU (1) AU2012322835A1 (zh)
BR (1) BR112014008464A2 (zh)
CA (1) CA2851516C (zh)
HK (1) HK1201064A1 (zh)
RU (1) RU2014113702A (zh)
SG (1) SG11201401226YA (zh)
WO (1) WO2013055825A2 (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9982020B2 (en) * 2011-10-10 2018-05-29 Nanovir Llc Antiviral compounds and methods for treating infections caused by double-stranded DNA viruses
WO2016022664A1 (en) 2014-08-05 2016-02-11 Nanovir Llc Antiviral compounds and methods for treating infections caused by double-stranded dna viruses

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995004732A1 (en) 1993-08-06 1995-02-16 Synphar Laboratories, Inc. Oligopeptide antiretroviral agents
WO1998037066A1 (en) 1996-02-26 1998-08-27 California Institute Of Technology Improved polyamides for binding in the minor groove of double stranded dna
CN1260006A (zh) 1996-02-26 2000-07-12 加利福尼亚州技术学院 双链dna和杂环低聚物之间复合物的形成
WO1998037067A1 (en) 1996-02-26 1998-08-27 California Institute Of Technology Design, synthesis and use of specific polyamide dna-binding ligands
US5998140A (en) 1996-07-31 1999-12-07 The Scripps Research Institute Complex formation between dsDNA and oligomer of cyclic heterocycles
AU749953B2 (en) 1996-08-01 2002-07-04 California Institute Of Technology Inhibition of gene transcription by polyamide DNA-binding ligands
WO2000015773A2 (en) 1998-09-11 2000-03-23 California Institute Of Technology Inhibition of oncogene transcription by synthetic polyamides
US6673940B1 (en) 1999-01-08 2004-01-06 California Institute Of Technology Compositions and methods relating to cyclic compounds that undergo nucleotide base pair-specific interactions with double-stranded nucleic acids
US7067622B2 (en) 2001-06-25 2006-06-27 Japan Science And Technology Agency Method of the solid phase synthesis of pyrrole-imidazole polyamide
BR0213988A (pt) 2001-11-07 2004-08-31 Pharmacia Corp Moduladores de poliamida de transcrição de cox2
BR0213989A (pt) 2001-11-07 2005-03-01 Pharmacia Corp Métodos para promover a absorção e acúmulo nuclear de poliamidas em células eucarióticas
DE602004027211D1 (de) 2003-01-16 2010-07-01 Femmepharma Holding Co Inc Vaginaler oder rektaler applikator und verfahren
US8524899B2 (en) 2003-03-04 2013-09-03 California Institute Of Technology Alternative heterocycles for DNA recognition
MXPA05011642A (es) 2003-04-30 2005-12-15 Pharmacia Corp Compuestos que tienen un resto biciclico condensado para unirse al surco menor del adn de doble hebra.
US8399013B2 (en) 2003-06-26 2013-03-19 Poly-Med, Inc. Partially absorbable fiber-reinforced composites for controlled drug delivery
WO2005033282A2 (en) * 2003-10-01 2005-04-14 Pharmacia & Upjohn Company Llc Polyamide compositions and therapeutic methods for treatment of human papilloma virus
DE10357677A1 (de) 2003-12-10 2005-07-14 Greiner Bio-One Gmbh Primer und Sonden zum Nachweis genitaler HPV-Genotypen
WO2007045096A1 (en) * 2005-10-21 2007-04-26 University Of Saskatchewan Oligoheteroaromatic luminiscent assemblies as high-affinity dna sequence-directed ligands
WO2007103584A2 (en) * 2006-03-09 2007-09-13 Nanovir, Llc Polyamides for treating human papilloma virus
US8993609B2 (en) 2006-05-04 2015-03-31 Nanovir, Llc Compounds for treating papilloma virus infection
ATE555108T1 (de) 2006-05-04 2012-05-15 Nanovir Llc Polyamide zur behandlung des menschlichen papilloma-virus

Also Published As

Publication number Publication date
JP2015502330A (ja) 2015-01-22
NZ623292A (en) 2016-02-26
WO2013055825A3 (en) 2013-06-13
US20130090362A1 (en) 2013-04-11
KR20140074996A (ko) 2014-06-18
WO2013055825A2 (en) 2013-04-18
CN104024247A (zh) 2014-09-03
SG11201401226YA (en) 2014-05-29
US9133228B2 (en) 2015-09-15
CA2851516A1 (en) 2013-04-18
EP2751096A2 (en) 2014-07-09
RU2014113702A (ru) 2015-11-20
EP2751096A4 (en) 2015-04-08
CN104024247B (zh) 2016-05-25
AU2012322835A1 (en) 2014-04-17
BR112014008464A2 (pt) 2017-04-11
CA2851516C (en) 2016-08-02

Similar Documents

Publication Publication Date Title
SG10201602013SA (en) Treatment for peanut allergy
GB201119111D0 (en) Illumination apparatus
EP2755612A4 (en) MARKET FRAME FOR ANKLE
HK1199649A1 (zh) 用於製備聚醯胺的方法
EP2780631A4 (en) CONNECTABLE LIGHTING DEVICE
EP2664845A4 (de) Beleuchtungsvorrichtung
GB2491411B (en) Exhaust after treatment device mode regulation
HK1201064A1 (zh) 有用於治療人類乳頭瘤病毒的被胍基取代的聚醯胺
ZA201404542B (en) Fabric treatment composition
ZA201308117B (en) Avian-based treatment
GB201105523D0 (en) Treatment method
GB2489207B (en) Waste treatment
GB201111247D0 (en) Treatment
GB201109119D0 (en) Treatment
GB201102272D0 (en) Treatment
GB201102274D0 (en) Treatment
GB201102266D0 (en) Treatment
GB201102270D0 (en) Treatment
GB201102265D0 (en) Treatment
GB201102267D0 (en) Treatment
GB201102268D0 (en) Treatment
GB201102288D0 (en) Treatment
GB201102284D0 (en) Treatment
GB201102269D0 (en) Treatment
GB201102277D0 (en) Treatment